Catherine Coste - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role: Director
Signature: /s/ Katie Kazem, Attorney-in-Fact
Issuer symbol: RNLX
Transactions as of: 01 Jul 2023
Transactions value $: $0
Form type: 3
Filing time: 03 Jul 2023, 16:19:12 UTC
Previous filing: 30 Jan 2023
Next filing: 07 Jul 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are benefically owned. Exhibit List - Exhibit 24 - Power of Attorney